Bio Sequence

Unveiling the FTO Retrieval of Multi-gene Elements within the AAV Domain

18 October 2023
2 min read

In the AAV field, common inventions involve the replacement and combination of expression-related gene regulatory elements. During FTO / novelty retrieval of sequences, it is generally not feasible to complete the retrieval with entire sequences. Instead, it's required to perform a combination search with major regulatory element sequences. The Patsnap Bio Sequence Database can satisfy the demand for such combination searches.

Firstly, click here to register a Patsnap Bio database account for free and go to the retrieval page. In the search options on the left, select " Combined" to get to the combination retrieval interface.

In the search box, input the sequences of the gene elements and target genes you want to query. If you want to search more than 3 sequences, click "Add another Sequence" (up to 6 sequences can be searched concurrently). For example, input the CMVE enhancer sequence, CBA promoter sequence, and target gene opSMN sequence, then choose patent or literature search.

It is important to note that Patsnap Bio is the most extensive sequence search platform for the Patsnap database. It incorporates AI with human-curated data for comprehensive handling of protein and nucleotide sequence data plucked from global patents, biological periodicals, and public repositories. Essential biological sequences are manually annotated, illuminating structural modifications to provide the most accurate sequence data and boost sequence retrieval efficiency.

Free registration is available for the Bio biological sequence database: https://bio.patsnap.com. Act now to expedite your sequence search tasks.

The FDA has granted approval for TOFIDENCE™ (tocilizumab-bavi), a biosimilar of ACTEMRA®, created by Bio-Thera Solutions
Latest Hotspot
3 min read
The FDA has granted approval for TOFIDENCE™ (tocilizumab-bavi), a biosimilar of ACTEMRA®, created by Bio-Thera Solutions
18 October 2023
Bio-Thera Solutions has made it known that its associate company, Biogen, was recently notified by FDA about the approval of TOFIDENCE (tocilizumab-bavi) in an intravenous mixture.
Read →
Oxitriptan Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs
Drug Insights
5 min read
Oxitriptan Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs
24 October 2023
This article summarized the latest R&D progress of oxitriptan, the Mechanism of Action for oxitriptan, and the drug target R&D trends for oxitriptan.
Read →
Unleashing the Power of pamiparib: A Comprehensive Review on R&D Breakthroughs
Drug Insights
4 min read
Unleashing the Power of pamiparib: A Comprehensive Review on R&D Breakthroughs
24 October 2023
This article summarized the latest R&D progress of pamiparib, the Mechanism of Action for pamiparib, and the drug target R&D trends for pamiparib.
Read →
 A Comprehensive Review of peginterferon beta-1a's R&D Innovations and Drug Target Mechanism
Drug Insights
4 min read
A Comprehensive Review of peginterferon beta-1a's R&D Innovations and Drug Target Mechanism
24 October 2023
This article summarized the latest R&D progress of peginterferon beta-1a, the Mechanism of Action for peginterferon beta-1a, and the drug target R&D trends for peginterferon beta-1a.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.